GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ovation Science Inc (XCNQ:OVAT) » Definitions » Valuation Rank

Ovation Science (XCNQ:OVAT) Valuation Rank


View and export this data going back to 2018. Start your Free Trial

What is Ovation Science Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Ovation Science Valuation Rank Related Terms

Thank you for viewing the detailed overview of Ovation Science's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Ovation Science Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ovation Science Inc (XCNQ:OVAT) » Definitions » Valuation Rank
Comparable Companies
XCNQ:PBF TSXV:LFST XCNQ:STRC.X TSX:WLLW TSXV:ENTG XCNQ:MGW XCNQ:PHRX XCNQ:STPH XCNQ:RAMM XCNQ:PLCN ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
OVATF:USA
Address
1166 Alberni Street, Suite 1003, Vancouver, BC, CAN, V6E 3Z3
Website
https://www.ovationscience.com
Ovation Science Inc. is a Canada-based company mainly engaged in providing topical and transdermal cannabis products under the "Ovation" brand label. It utilizes the patented "Invisicare" delivery technology, which it acquired for exclusive use for cannabis-formulated products. The group has two geographical segments: Canada and the United States. Key revenue is generated from Canada.
Executives
Shane Dungey Director
Doreen Mcmorran Director
Ian Howard Director
David K. Ryan Director